Iron Overload, Chelation Therapy and Survival in Lower-Risk Myelodysplastic Syndromes: State of the Evidence
Journal Title: International Blood Research & Reviews - Year 2014, Vol 2, Issue 3
Abstract
Myelodysplastic syndromes (MDS) are clonal stem cell disorders that primarily affect older persons and are associated with peripheral blood cytopenias, increased risk of conversion to acute myeloid leukemia and shortened survival. Treatment strategies in MDS are guided by patient risk categories, with higher-risk patients receiving more aggressive interventions. Patients with lower-risk MDS receive less aggressive therapies or supportive care/red blood cell transfusion. Transfusion-dependent patients with lower-risk MDS are likely to develop iron overload because of their longer predicted survival and, hence, greater transfusion burden. Transfusion requirement and elevated serum ferritin further complicate the treatment landscape because they have dose-dependent effects on overall and leukemia-free survival, with increasing serum ferritin levels associated with increased risk of death. Lower iron burden could provide a survival benefit, and an association with improved survival has been shown in retrospective studies. However, lack of random assignment to treatment is the major flaw in these studies, which potentially introduces patient selection bias. Despite the lack of randomization and other issues with trial design, available studies have shown consistent results, which suggest a survival benefit in transfusion-dependent patients with MDS who have received chelation therapy. Prospective studies are needed to confirm this observation. The possible mechanisms by which chelation therapy appears to benefit patients with MDS need further research. The data suggesting a survival benefit from chelation therapy in lower-risk, iron-overloaded patients with MDS are reviewed, including the strength of evidence, recent scientific advances and ongoing clinical trials.
Authors and Affiliations
Roger M. Lyons
Keywords
Related Articles
- EP ID EP242461
- DOI 10.9734/IBRR/2014/8580
- Views 114
- Downloads 0
Immunological and Hematological Profiles of Human Immunodeficiency Virus Positive Patients on Antiretroviral Treatment Followed at Institute Pasteur of Ivory Coast
Aims: The immune system and some of the organs of HIV positive patients may be subject of some disruptions caused by Anti-Retroviral Treatment (ART). This study has been initiated in order to assess the impact of ART on...
Antisickling Activity and Membrane Stabilizing Effect of Anthocyanins Extracts from Adansonia digitata L. Barks on Sickle Blood Cells
Background: Parts of baobab tree (Adansonia digitata) including especially the barks are commonly used for their medicinal properties. Aims: The aim of this work is to evaluate the antisickling activity of baobab tree b...
Assessment of CD4 Count and Some Haematological Parameters of HIV Positive Patients Co-infected with Hepatitis B Virus in Osun State, Nigeria
Background: Increased morbidity and mortality rates have been reported among patients co-infected with Human Immunodeficiency Virus (HIV) and Hepatitis B Virus (HBV). Aims: To determine the prevalence of HBV infection am...
Variation in Blood Indices in Cases of Anemias Coexisting with HbE from Eastern India
Hemoglobin E is one of the most common forms of abnormal hemoglobin, related to hemoglobinopathies in the world. It can result in a heterogeneous group of disorders ranging from asymptomatic to severe anemia with regular...
Prevalence of Anaemia among Children Attending Paediatrics Department of UDUTH, Sokoto, North-Western Nigeria
Introduction: Anaemia is a global public health problem. It affects more than 56 million people globally, two thirds of them being from developing countries. This study was designed to investigate the prevalence and type...